Explore Our Publications
At Magnolia Innovation, we are constantly striving to contribute meaningful data and analysis to the larger healthcare conversation.
Below are some of the independent and collaborative publications we have worked on recently.
BMT InfoNet Partners With Market Research Firm Magnolia Innovation to Better Understand Their Community’s Needs
Magnolia Innovation volunteers its market research expertise to uncover user experience issues to support BMT InfoNet website
BMT InfoNet Partners With Market Research Firm Magnolia Innovation to Better Understand Their Community’s Needs
Magnolia Innovation volunteers its market research expertise to uncover user experience issues to support BMT InfoNet website
Academic Execs Share How Pharma Should Engage With Oncology Customers
Academic Institution Executives Weigh In on the Importance of Knowing the Business Side of Oncology and the Impact of the Cross-Functional Teams That Exist within Pharma
Academic Execs Share How Pharma Should Engage With Oncology Customers
Academic Institution Executives Weigh In on the Importance of Knowing the Business Side of Oncology and the Impact of the Cross-Functional Teams That Exist within Pharma
Understanding the Impact of Long-chain Fatty Acid Oxidation Disorders for Patients and Caregivers
The Substantial Impact on Quality of Life for Individuals with LC-FAOD and Their Caregivers
Understanding the Impact of Long-chain Fatty Acid Oxidation Disorders for Patients and Caregivers
The Substantial Impact on Quality of Life for Individuals with LC-FAOD and Their Caregivers
Understanding the Impact of Long-chain Fatty Acid Oxidation Disorders for Patients and Caregivers
The Substantial Impact on Quality of Life for Individuals with LC-FAOD and Their Caregivers
Understanding Caregiver Descriptions of Initial Signs and Symptoms to Improve Diagnosis to Metachromatic Leukodystrophy
How Recognizing early signs can lead to earlier diagnosis and intervention in MLD patients
Understanding Caregiver Descriptions of Initial Signs and Symptoms to Improve Diagnosis to Metachromatic Leukodystrophy
How Recognizing early signs can lead to earlier diagnosis and intervention in MLD patients
An International Study of Caregiver – Reported Burden and Quality of Life in Metachromatic Leukodystrophy
How MLD Caregivers Lives are Negatively Affected By the Burden of care
An International Study of Caregiver – Reported Burden and Quality of Life in Metachromatic Leukodystrophy
How MLD Caregivers Lives are Negatively Affected By the Burden of care
C-Suite Insights: Are Oncology Pharma Teams Meeting Expectations?
A Customer-Driven Discussion About How Elevating Acumen In The Business of Oncology Can Strengthen Customer Impact
C-Suite Insights: Are Oncology Pharma Teams Meeting Expectations?
A Customer-Driven Discussion About How Elevating Acumen In The Business of Oncology Can Strengthen Customer Impact
Stress, Inflammation, and Suboptimal Treatment Outcomes
psychoneuroimmunology deepens our understanding of the mind-body connection and biological pathways through which mental and physical health interact.
Stress, Inflammation, and Suboptimal Treatment Outcomes
psychoneuroimmunology deepens our understanding of the mind-body connection and biological pathways through which mental and physical health interact.
Researching, Recognizing, and Reaching the Rare
Our team of market researchers, data scientists and consultants built a patient finding strategy tailored to our client’s needs
Researching, Recognizing, and Reaching the Rare
Our team of market researchers, data scientists and consultants built a patient finding strategy tailored to our client’s needs
Many Vendors or One Partner?
Read how a small biopharma company relied on a single vendor to launch a market-leading drug.
Many Vendors Or One Partner?
Read how a small biopharma company relied on a single vendor to launch a market-leading drug.
COVID-19: Impact on the Rare Disease Community
Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic
COVID-19: Impact on the Rare Disease Community
Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic
Oncologist Segmentation
Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists
Oncologist Segmentation
Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists
Benchmarking the COVID-19 Pandemic
Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic
Benchmarking the COVID-19 Pandemic
Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic
The Hidden Burden
Optimize commercial efforts by understanding the common challenges in the rare disease landscape
The Hidden Burden
Optimize commercial efforts by understanding the common challenges in the rare disease landscape
Understanding the Burden of Primary Hyperoxaluria Type 1 (PH1)
Understand the Debilitating effects of ph1 to identify the opportunities for Easier diagnosis and effective therapies
Understanding the Burden of Primary Hyperoxaluria Type 1 (PH1)
Understanding the Debilitating effects of Ph1 to identify the Opportunities for Easier diagnosis and effective therapies
